课题基金 / 基金详情

Regulation of Vascular Redox State by Thioredoxin

Regulation of Vascular Redox State by Thioredoxin
硫氧还蛋白对血管氧化还原状态的调节
批准号:
7029361
负责人:
Richard E. Lee
金额:
$35.11万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-03-31

项目摘要

项目成果

Richard E. Lee的其他基金

相似基金

相关文献

中文摘要
翻译
硫氧还蛋白是一种强大的活性氧清除剂。硫氧还蛋白相互作用蛋白(TXNIP;也 被称为VDUP1或维生素D3上调蛋白1)与硫氧还蛋白结合,现在已知是一种 硫氧还蛋白活性的重要抑制剂。我们先前已经证明TXNIP本身是一个氧化还原敏感基因 一种会损害细胞存活的蛋白质产品。此外,TXNIP的过表达抑制了细胞的生长 反应,以及生长因子信号,如PDGF,需要降解TXNIP以允许硫氧还蛋白介导 转录活性。因此,令人信服的证据现在出现了,TXNIP,一个默默无闻的孤儿 基因产物仅在几年前,由于其直接抑制多种信号事件,是各种信号事件的关键调节因子 硫氧还蛋白活性。由于细胞内硫氧还蛋白水平趋于恒定,因此TXNIP可能是一个关键 控制细胞内氧化还原状态的机制。活性氧类参与多个阶段的 动脉硬化。在这里,我们提供了关于硫氧还蛋白/TXNIP在血管中潜在重要性的初步数据 并描述其在加速动脉粥样硬化中的潜在作用。一个有趣的新发现是,虽然 许多刺激抑制TXNIP从而增加硫氧还蛋白活性,葡萄糖强烈地诱导TXNIP并抑制 硫氧还蛋白的体外和体内活性。我们建议探索这一中心假设,即监管 TXNIP损伤血管硫氧还蛋白活性,导致氧化应激增加,促进动脉粥样硬化。 由于葡萄糖诱导TXNIP,这些实验与糖尿病血管疾病有特别的相关性。我们 描述三个假设驱动的目标,它们将探索TXNIP在体外血管病理生理学中的作用 在活体内。目标是: 目的1.验证葡萄糖诱导TXNIP促进血管内皮细胞促凋亡状态的假说 通过阻断硫氧还蛋白的抗氧化功能。 目的2.用组织特异性方法验证TXNIP调节糖尿病小鼠动脉氧化还原状态的假说 有针对性的基因缺失方法。 目的3.验证血栓素NIP调控参与动脉粥样硬化形成的假说。
英文摘要
Thioredoxin is a powerful scavenger of reactive oxygen species. Thioredoxin-interacting protein (Txnip; also known as VDUP1 or Vitamin D3 Up-regulated Protein 1) binds to thioredoxin and is now known to be an important inhibitor of thioredoxin activity. We have previously shown that Txnip is itself a redox-sensitive gene with a protein product that impairs cell survival. Furthermore, Txnip overexpression blocks cellular growth responses, and growth factor signals such as PDGF require degradation of Txnip in order to allow thioredoxinmediated transcriptional activity. Thus, compelling evidence has now emerged that Txnip, an obscure orphan gene product only a few years ago, is a critical regulator of diverse signaling events due to its direct inhibition of thioredoxin activity. Because intracellular thioredoxin levels tend to be constant, Txnip may therefore be a key mechanism for controlling intracellular redox state. Reactive oxygen species participate in many stages of atherosclerosis. Here we present preliminary data on the potential importance of Thioredoxin/Txnip in vascular disease and describe its potential role in accelerating atherosclerosis. An intriguing new finding is that while many stimuli suppress Txnip and thus increase thioredoxin activity, glucose robustly induces Txnip and inhibits thioredoxin activity both in vitro and in vivo. We propose exploration of the central hypothesis that regulation of Txnip impairs vascular thioredoxin activity, leading to increased oxidative stress and promoting atherosclerosis. Because glucose induces Txnip, these experiments have particular relevance to diabetic vascular disease. We describe three hypothesis-driven Aims that will explore the role of Txnip in vascular pathophysiology in vitro and in vivo. The Aims are: Aim 1. To test the hypothesis that the induction of Txnip by glucose promotes a pro-apoptotic state in vascular cells through blockade of thioredoxin's antioxidant function. Aim 2. To test the hypothesis that Txnip regulates redox state in diabetic arteries in mice using tissue-specific targeted gene deletion approaches. Aim 3. To test the hypothesis that regulation of Txnip participates in the promotion of atherosclerosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spectinomycin analogs for NTM infections
Spectinomycin analogs for NTM infections
Spectinomycin analogs for NTM infections
Training in the Design and Development of Infectious Disease Therapeutics
海外基金